DMJ Archive Login Register My Manuscripts Contact

This academic journal follows and is published in accordance with the ethical guidelines described by the Good Publication Practice Guidelines for Medical Journals 2nd (Korean Association of Medical Journal Editors, KAMJE; and Guidelines on Good Publication (Committee on Publication Ethics, COPE;

1. Registration of Clinical Trial Research

It is recommended that clinical trial research is registered under certified institutions, such as the Clinical Research Information Service-Republic of Korea (, the World Health Organization (WHO), or the International Committee of Medical Journal Editors (ICMJE).

2. Disclosure of Conflict of Interest

The corresponding author is required to disclose to the editor any and all factors that could affect the interpretation of results, such as financial incentives from pharmaceutical companies or associations, political pressure from special interest groups, and academic related issues. The source of the financial support used for studies must be clearly identified without exception.

3. Written Agreement

For clinical research, the authors must be able to produce the patient’s written consent and the approval of the Institutional Review Board (IRB), and the copies of documentations must be retained. In the event that they are needed, the editor or reviewer may request for them for submission.

4. Regulations of Human and Experimental Animal Rights

All studies performed on humans must be performed in accordance with the ethical standards of the Declaration of Helsinki. The institution’s ethics committee must approve all experiments involving animals such as mammals and birds, and the use and management of test animals must be in accordance with the national laws and institutional regulations. The experiment plans approved by the experimental animal ethics committee must be available for submission upon request when deemed necessary by the editors or the reviewers.

5. Author’s Qualifications

The authors of the paper must have met all of the following criteria:

1) Contributed to the creation of the basic concept and design of the study, as well as the analysis and the interpretation of the data.
2) Written the manuscript, edited a major portion, or made a significant contribution that improved the contents of the manuscript.
3) Agreed to the contents of the final manuscript. If there are more than 6 authors, the contribution of each author must be clearly listed.

6. Creativity and Publishing Guidelines

The submitted manuscripts must be original. The manuscript may not be considered for publication in another magazine or journal. Additionally, no part of the manuscript may be published elsewhere without permission from the editorial board. In the event that a publishing violation has occurred, the journal will be notified, the offenders may be penalized, and the institutions affiliated with the authors will be notified.

7. Secondary Publication

Only if the manuscript meets the requirements of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals ( can the manuscript be republished in another magazine or journal.

Copyright© Korean Diabetes Association. All rights reserved.
Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064   Fax: +82-2-714-9084   E-mail:      Privacy Policy      Powered by M2community